Francis Capital Maintains 5.7% Stake in BioCardia (BCDA)

Ticker: BCDA · Form: SC 13G/A · Filed: Feb 2, 2024 · CIK: 925741

Biocardia, Inc. SC 13G/A Filing Summary
FieldDetail
CompanyBiocardia, Inc. (BCDA)
Form TypeSC 13G/A
Filed DateFeb 2, 2024
Risk Levellow
Pages5
Reading Time5 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: institutional-ownership, amendment, biotech

TL;DR

**Francis Capital still holds 5.7% of BioCardia, signaling continued interest.**

AI Summary

Francis Capital Management, LLC and Catalysis Partners, LLC filed an amended SC 13G/A on February 2, 2024, indicating their beneficial ownership in BioCardia, Inc. (BCDA) as of December 31, 2023. Catalysis Partners, LLC reported zero sole voting power and zero sole dispositive power, while Francis Capital Management, LLC reported shared voting and dispositive power over 1,000,000 shares, representing 5.7% of BioCardia's Common Stock. This matters to investors because it shows a significant institutional holder has maintained a substantial stake, potentially signaling confidence in the company's future, or at least no immediate plans to divest their entire position.

Why It Matters

This filing confirms that a major institutional investor, Francis Capital Management, LLC, continues to hold a significant portion of BioCardia's stock, which can influence market perception and liquidity.

Risk Assessment

Risk Level: low — The filing indicates a stable ownership position by an institutional investor, not a significant change that would introduce new risks.

Analyst Insight

Investors should note the continued institutional ownership by Francis Capital Management, LLC, which could provide some stability, but should not solely rely on this for investment decisions. Further research into BioCardia's financials and pipeline is warranted.

Key Numbers

  • 1,000,000 — Shares Beneficially Owned (Number of BioCardia, Inc. Common Stock shares held by Francis Capital Management, LLC)
  • 5.7% — Percentage of Class (The percentage of BioCardia, Inc.'s Common Stock beneficially owned by Francis Capital Management, LLC)
  • $0.001 — Par Value (The par value per share of BioCardia, Inc. Common Stock)

Key Players & Entities

  • BioCardia, Inc. (company) — the subject company whose securities are being reported
  • Francis Capital Management, LLC (company) — a reporting person beneficially owning shares
  • Catalysis Partners, LLC (company) — a reporting person with zero beneficial ownership reported in this amendment
  • 1,000,000 (dollar_amount) — number of shares beneficially owned by Francis Capital Management, LLC
  • 5.7% (dollar_amount) — percentage of BioCardia's class of securities beneficially owned by Francis Capital Management, LLC
  • December 31, 2023 (date) — the date of the event requiring the filing

Forward-Looking Statements

  • Francis Capital Management, LLC will maintain its significant stake in BioCardia, Inc. for the foreseeable future. (Francis Capital Management, LLC) — medium confidence, target: December 31, 2024

FAQ

Who are the reporting persons in this SC 13G/A filing for BioCardia, Inc.?

The reporting persons are Francis Capital Management, LLC and Catalysis Partners, LLC, as stated on the cover page and in the filing details.

What percentage of BioCardia, Inc.'s Common Stock does Francis Capital Management, LLC beneficially own as of December 31, 2023?

Francis Capital Management, LLC beneficially owns 5.7% of BioCardia, Inc.'s Common Stock, as indicated in the filing.

How many shares of BioCardia, Inc. Common Stock does Francis Capital Management, LLC have shared voting and dispositive power over?

Francis Capital Management, LLC has shared voting and dispositive power over 1,000,000 shares of BioCardia, Inc. Common Stock, according to the filing.

What is the CUSIP number for BioCardia, Inc.'s Common Stock?

The CUSIP number for BioCardia, Inc.'s Common Stock is 09060U507, as listed on the cover page of the filing.

What is the significance of Catalysis Partners, LLC being listed as a reporting person but showing zero beneficial ownership?

While listed as a reporting person, Catalysis Partners, LLC reported 0 shares for both sole voting power and sole dispositive power, indicating they do not beneficially own shares of BioCardia, Inc. as of the reporting date, or their ownership is below the reporting threshold for this specific filing.

Filing Stats: 1,361 words · 5 min read · ~5 pages · Grade level 10.2 · Accepted 2024-02-02 14:06:12

Filing Documents

If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: (e) [x] Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 (g) [x] Parent Holding Company or control person in accordance with Rule 13d-1(b)(1)(ii)(G)

Ownership

Item 4. Ownership (i) Catalysis Partners, LLC (a) Amount beneficially owned: 0 (b) Percent of class: 0% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 0 (ii) Francis Capital Management, LLC (a) Amount beneficially owned: 0 (b) Percent of class: 0% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 0 (iii) John Francis (a) Amount beneficially owned: 0 (b) Percent of class: 0% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 0 CUSIP No. 09060U507 13G/A Page 5 of 7 Pages

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ X ].

Ownership of More Than Five Percent on Behalf of Another Person

Item 6. Ownership of More Than Five Percent on Behalf of Another Person: Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: Not Applicable

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group: Not Applicable

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group: Not Applicable

Certifications

Item 10. Certifications: Each of the Reporting Persons makes the following certification: By signing below each Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Date: February 2, 2024 CATALYSIS PARTNERS, LLC By: Francis Capital Management, LLC, its Managing Member By: /s/ John Francis Name: John Francis Title: Managing Member FRANCIS CAPITAL MANAGEMENT, LLC By: /s/ John Francis Name: John Francis Title: Managing Member JOHN FRANCIS By: /s/ John Francis CUSIP No. 09060U507 13G/A Page 6 of 7 Pages EXHIBIT A Joint Filing Agreement Pursuant to Rule 13d-1 This agreement is made pursuant to Rule 13d-l(k)(1) under the Securities Exchange Act of 1934, as amended (the "Act") by and among the parties listed below, each referenced to herein as a "Joint Filer". The Joint Filers agree that a statement of beneficial ownership as required by Sections 13(g) or 13(d) of the Act and the rules thereunder may be filed on each of his, her or its behalf on Schedule 13G or Schedule 13D, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1(k). Dated: February 2, 2024 CATALYSIS PARTNERS, LLC By: Francis Capital Management, LLC, its General Partner By: /s/ John Francis Name: John Francis Title: Managing Member FRANCIS CAPITAL MANAGEMENT, LLC By: /s/ John Francis Name: John Francis Title: Mana

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.